Ly6H mRNA expression was significantly higher in progesterone receptor (PgR) positive breast cancer (n=215) than PgR negative breast cancer (n=149) in Stickeler [47] and TCGA (Unpublished, NCI) and Chang [127] studies. Here, LY6H is linked to breast cancer.